DUAKLIR

Drug Circassia Pharmaceuticals Inc
Total Payments
$24,828
Transactions
53
Doctors
8
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2018 $24,828 53 8

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $21,500 8 86.6%
Food and Beverage $1,775 27 7.1%
Travel and Lodging $1,553 18 6.3%

Top Doctors Receiving Payments for DUAKLIR

Doctor Specialty Location Total Records
, M.D Internal Medicine Livonia, MI $4,446 7
, MD Pulmonary Disease Franklin, TN $3,007 8
, MD Pulmonary Disease Duncanville, TX $2,936 9
, M.D Internal Medicine Columbia, MD $2,932 8
, MD Internal Medicine Lexington, KY $2,888 6
, MD Pulmonary Disease Newark, DE $2,879 5
, MD Pulmonary Disease Westminster, CA $2,870 5
Ruxana Sadikot Critical Care Medicine Gainesville, FL $2,870 5

About DUAKLIR

DUAKLIR is a drug associated with $24,828 in payments to 8 healthcare providers, recorded across 53 transactions in the CMS Open Payments database. The primary manufacturer is Circassia Pharmaceuticals Inc.

Payment data is available from 2018 to 2018. In 2018, $24,828 was paid across 53 transactions to 8 doctors.

The most common payment nature for DUAKLIR is "Consulting Fee" ($21,500, 86.6% of total).